Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Cognex Corp’s stock clocked out at $44.76, up 4.73% from its previous closing price of $42.74. In other words, the price has increased by $4.73 from its previous closing price. On the day, 1.59 million shares were traded. CGNX stock price reached its highest trading level at $44.87 during the session, while it also had its lowest trading level at $42.9.
Ratios:
To gain a deeper understanding of CGNX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 32.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.84. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On July 10, 2025, Melius Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $60.
TD Cowen Upgraded its Hold to Buy on April 28, 2025, while the target price for the stock was maintained at $35.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 11 ’25 when Kuechen Joerg sold 7,991 shares for $32.97 per share. The transaction valued at 263,469 led to the insider holds 0 shares of the business.
JOERG KUECHEN bought 7,991 shares of CGNX for $263,469 on Mar 11 ’25. On Feb 24 ’25, another insider, Gerst Carl, who serves as the EVP, Vision & ID Products of the company, sold 6,803 shares for $32.73 each. As a result, the insider received 222,630 and left with 4,566 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGNX now has a Market Capitalization of 7520028672 and an Enterprise Value of 7370141696. As of this moment, Cognex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 62.65, and their Forward P/E ratio for the next fiscal year is 38.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.08 while its Price-to-Book (P/B) ratio in mrq is 4.99. Its current Enterprise Value per Revenue stands at 7.929 whereas that against EBITDA is 44.793.
Stock Price History:
The Beta on a monthly basis for CGNX is 1.49, which has changed by 0.13230455 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, CGNX has reached a high of $44.38, while it has fallen to a 52-week low of $22.67. The 50-Day Moving Average of the stock is 24.98%, while the 200-Day Moving Average is calculated to be 30.33%.
Shares Statistics:
It appears that CGNX traded 1.91M shares on average per day over the past three months and 2003190 shares per day over the past ten days. A total of 167.90M shares are outstanding, with a floating share count of 167.43M. Insiders hold about 0.28% of the company’s shares, while institutions hold 97.96% stake in the company. Shares short for CGNX as of 1753920000 were 5337958 with a Short Ratio of 2.80, compared to 1751241600 on 5761618. Therefore, it implies a Short% of Shares Outstanding of 5337958 and a Short% of Float of 3.56.
Dividends & Splits
With its trailing 12-month dividend rate of 0.315, CGNX has a forward annual dividend rate of 0.32. Against a Trailing Annual Dividend Yield of 0.0073751495The stock’s 5-year Average Dividend Yield is 0.56. The current Payout Ratio is 49.59% for CGNX, which recently paid a dividend on 2025-08-14 with an ex-dividend date of 2025-08-14. Stock splits for the company last occurred on 2017-12-04 when the company split stock in a 2:1 ratio.
Earnings Estimates
The current assessment of Cognex Corp (CGNX) involves the perspectives of 15.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.22, with high estimates of $0.25 and low estimates of $0.19.
Analysts are recommending an EPS of between $0.98 and $0.86 for the fiscal current year, implying an average EPS of $0.92. EPS for the following year is $1.16, with 17.0 analysts recommending between $1.55 and $1.02.
Revenue Estimates
In the current quarter, 16 analysts expect revenue to total $261.07M. It ranges from a high estimate of $269.88M to a low estimate of $246M. As of the current estimate, Cognex Corp’s year-ago sales were $234.74MFor the next quarter, 16 analysts are estimating revenue of $237.09M. There is a high estimate of $240M for the next quarter, whereas the lowest estimate is $234M.
A total of 19 analysts have provided revenue estimates for CGNX’s current fiscal year. The highest revenue estimate was $986.46M, while the lowest revenue estimate was $943M, resulting in an average revenue estimate of $965.58M. In the same quarter a year ago, actual revenue was $914.51MBased on 19 analysts’ estimates, the company’s revenue will be $1.06B in the next fiscal year. The high estimate is $1.15B and the low estimate is $1.03B.
